SCHEMBL30392529

SCHEMBL30392529

COc1ccc(CN(C)c2cc(Nc3cccn(-c4ccc(C5OCCO5)cn4)c3=O)nn3c(C(=O)N[C@@H]4C[C@@H]4F)cnc23)cc1

nearest known ligand 0.58

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ TYK2 P29597 20/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26100011 1.00 TYK2 (0.58) TYK2
SCHEMBL18161078 0.90 TYK2 (0.62) TYK2
SCHEMBL26101378 0.90 TYK2 (0.61) TYK2
SCHEMBL16794651 0.89 TYK2 (0.60) TYK2
SCHEMBL18161079 0.88 TYK2 (0.69) TYK2
SCHEMBL16812532 0.88 TYK2 (0.58) TYK2
SCHEMBL30392624 0.87 TYK2 (0.41) TYK2
SCHEMBL26098984 0.87 TYK2 (0.41) TYK2
SCHEMBL30392548 0.86 TYK2 (0.41) TYK2
SCHEMBL26100209 0.86 TYK2 (0.41) TYK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4423086-A1 TYK2 DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2024-09-04 — — EP disclosed
WO-2023076161-A1 TYK2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-05-04 — — WO disclosed
Send feedback